Calyxt, Inc. Stock Nasdaq
Equities
CBUS
US17166A1016
Advanced Medical Equipment & Technology
Sales 2024 * | 2.17M 2.96M | Sales 2025 * | 8.69M 11.88M | Capitalization | 206M 282M |
---|---|---|---|---|---|
Net income 2024 * | -82M -112M | Net income 2025 * | -88M -120M | EV / Sales 2024 * | 95.2 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 23.7 x |
P/E ratio 2024 * |
-2.95
x | P/E ratio 2025 * |
-3.83
x | Employees | 183 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.74% |
Latest transcript on Calyxt, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Rory Riggs
CEO | Chief Executive Officer | 71 | - |
Wade King
DFI | Director of Finance/CFO | 67 | - |
Peter Beetham
PSD | President | 61 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rory Riggs
CEO | Chief Executive Officer | 71 | - |
Mark Finn
BRD | Director/Board Member | 81 | - |
Keith Walker
BRD | Director/Board Member | 76 | - |
1st Jan change | Capi. | |
---|---|---|
+4.85% | 212B | |
+9.86% | 188B | |
+31.11% | 157B | |
+34.08% | 114B | |
+3.54% | 64.01B | |
+19.45% | 54.88B | |
+1.63% | 48.83B | |
-3.12% | 39.3B | |
+1.93% | 35.97B |